Literature DB >> 8484692

Expression of systemic lupus erythematosus in various ethnic Jewish Israeli groups.

A J Wysenbeek1, L Leibovici, A Weinberger, D Guedj.   

Abstract

OBJECTIVES: To assess the expression of systemic lupus erythematosus (SLE) in Jewish Israeli patients according to ethnic origin.
METHODS: Eighty four patients with SLE were divided into groups according to origin and compared for history, physical examination, and laboratory variables.
RESULTS: Patients of Sephardic origin had more serious disease manifestations than Ashkenazi patients in 60 of the 76 variables examined. They had significantly worse muscle pain, alopecia, and cutaneous vasculitis, higher antibodies to DNA and erythrocyte sedimentation rate, and significantly lower complement and leucocytes. Sephardic patients were divided into subgroups according to country: Mediterranean area, Iran-Iraq-India, and Yemen. All three subgroups had more serious disease manifestations than the Ashkenazi group, and the Yemenite patients had the most serious manifestations among the Sephardic subgroups. The Sephardic patients had a significantly lower education level, but only origin, and not education level or age, was significantly related to disease manifestations on multivariate analysis.
CONCLUSION: More serious manifestations of SLE are found among Jewish patients of Sephardic origin, but these are not related to level of education or age.

Entities:  

Mesh:

Year:  1993        PMID: 8484692      PMCID: PMC1005624          DOI: 10.1136/ard.52.4.268

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  Analysis of biochemical genetic data on Jewish populations: II. Results and interpretations of heterogeneity indices and distance measures with respect to standards.

Authors:  S Karlin; R Kenett; B Bonné-Tamir
Journal:  Am J Hum Genet       Date:  1979-05       Impact factor: 11.025

2.  Estrogen metabolism in systemic lupus erythematosus: patients and family members.

Authors:  R G Lahita; L Bradlow; J Fishman; H G Kunkel
Journal:  Arthritis Rheum       Date:  1982-07

3.  Trends in recent systemic lupus erythematosus mortality rates.

Authors:  M F Gordon; P D Stolley; R Schinnar
Journal:  Arthritis Rheum       Date:  1981-06

4.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.

Authors:  C J Michet; C H McKenna; L R Elveback; R A Kaslow; L T Kurland
Journal:  Mayo Clin Proc       Date:  1985-02       Impact factor: 7.616

5.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

6.  Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States.

Authors:  R A Kaslow; A T Masi
Journal:  Arthritis Rheum       Date:  1978-05

7.  A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis.

Authors:  E M Ginzler; H S Diamond; M Weiner; M Schlesinger; J F Fries; C Wasner; T A Medsger; G Ziegler; J H Klippel; N M Hadler; D A Albert; E V Hess; G Spencer-Green; A Grayzel; D Worth; B H Hahn; E V Barnett
Journal:  Arthritis Rheum       Date:  1982-06

8.  Ethnic difference in the prevalence of systemic lupus erythematosus.

Authors:  H H Hart; R R Grigor; D E Caughey
Journal:  Ann Rheum Dis       Date:  1983-10       Impact factor: 19.103

9.  Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii.

Authors:  M K Serdula; G G Rhoads
Journal:  Arthritis Rheum       Date:  1979-04

10.  Systemic lupus erythematosus--survival patterns. Experience with 609 patients.

Authors:  D J Wallace; T Podell; J Weiner; J R Klinenberg; S Forouzesh; E L Dubois
Journal:  JAMA       Date:  1981-03-06       Impact factor: 56.272

View more
  1 in total

1.  Expression of rheumatoid arthritis in two ethnic Jewish Israeli groups.

Authors:  M Amit; D Guedj; A J Wysenbeek
Journal:  Ann Rheum Dis       Date:  1996-01       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.